Jesús de Blas
Jesús de Blas publishes mostly in Organic Chemistry, Molecular Biology and Spectroscopy, on topics such as Chemical Synthesis and Analysis, Asymmetric Synthesis and Catalysis and Monoclonal and Polyclonal Antibodies Research.
- World rank
- #5,123,053 of 7,710,434 ranked researchers
- Rank in Spain
- #119,700 of 204,306
- Works
- 22
- Citations
- 591
- Citations per work
- 26.9
What does Jesús de Blas research?
Jesús de Blas's work is mostly in Chemistry (56%), Biochemistry, Genetics and Molecular Biology (28%), Medicine (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1256.3%
- Chemistry1256.3%
- Life Sciences628.1%
- Everything else29.3%
- Health Sciences16.3%
- Medicine16.3%
- 1Organic Chemistry45% of their works
- 2Molecular Biology28% of their works
- 3Spectroscopy8% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Physical and Theoretical Chemistry2% of their works
- 6Inorganic Chemistry2% of their works
Research topics
- Chemical Synthesis and Analysis
- Asymmetric Synthesis and Catalysis
- Monoclonal and Polyclonal Antibodies Research
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Biological Evaluation
- Sulfur-Based Synthesis Techniques
- Quinazolinone synthesis and applications
- Advanced biosensing and bioanalysis techniques
Which keywords describe Jesús de Blas's research?
The keywords of their largest research topics: Drug Discovery, Peptide Synthesis, Synthesis, Anticancer, Antimicrobial, Biological Evaluation, Medicinal Chemistry and Enantioselective Reactions.
- DNA nanotechnology
- Sulfur Bond Formation
- Quinazoline
- Indirubin
- Antimicrobial Activity
- Organocatalysis
- Enantioselective Reactions
- Biological Evaluation
- Anticancer
- Peptide Synthesis
- Drug Discovery
- Synthesis
- Antimicrobial
- Medicinal Chemistry
- Fc Receptors
- Therapeutic Antibodies
- Biological Activities
- Phenothiazines
- Quinoxaline
- Transition-Metal-Catalyzed
- Self-Assembly
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Drug Discovery101 topic
- Peptide Synthesis101 topic
- Synthesis93 topics
- Anticancer62 topics
- Antimicrobial62 topics
- Biological Evaluation62 topics
- Medicinal Chemistry62 topics
- Enantioselective Reactions41 topic
- Fc Receptors41 topic
- Organocatalysis41 topic
- Therapeutic Antibodies41 topic
- Antimicrobial Activity31 topic
- Biological Activities31 topic
- Indirubin31 topic
- Phenothiazines31 topic
- Quinazoline31 topic
- Quinoxaline31 topic
- Sulfur Bond Formation31 topic
- Transition-Metal-Catalyzed31 topic
- DNA nanotechnology21 topic
- Self-Assembly21 topic
Where does Jesús de Blas work?
Jesús de Blas's main affiliation in the publication record is Eli Lilly (Spain), Spain.
How many publications and citations does Jesús de Blas have?
OpenAlex counts 22 works and 591 citations for Jesús de Blas, an h-index of 10, ranking #5,123,053 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jesús de Blas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.